The 10th Winter Arrhythmia School is a collaboration between the Schulich Heart Program at University of Toronto, New York University, and Montreal Heart Institute. This year the educational program is divided into two streams: a devices stream and an electrophysiology stream, incorporated together for sessions of common interest. The combined sessions will be focused on innovations in device therapies, ablation approaches, as well as anti-arrhythmic and anti-thrombotic pharmacology.

This course is designed to provide the learner with the most up-to-date review of lead management and to give an in-depth review of indications for lead extraction and management of device infections as well as available tools and technology for extraction. A live extraction case will be featured, followed by a panel discussion by experts in the field.

Program faculty will review detailed illustrative cases with a step-by-step analysis, providing a current, in-depth review of approaches to catheter ablation for the spectrum of cardiac arrhythmias including atrial fibrillation, complex atrial arrhythmias after AF ablation or in congenital heart disease, atrial tachycardia’s and atypical flutters, and ventricular arrhythmias with or without associated heart disease.

BOSTON, May 13, 2009 — Safe and effective management of patients with cardiovascular implantable devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators (ICDs) is a complex and evolving issue. To ensure that physicians and facilities are adequately prepared to determine if and when lead extraction is necessary and to give patients the best possible care during these procedures, the Heart Rhythm Society has developed Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus Statement on Facilities, Training, Indications and Patient Management.The consensus statement was released today at Heart Rhythm 2009, the Society’s 30th Annual Scientific Sessions.